Market Cap 1.51B
Revenue (ttm) 0.00
Net Income (ttm) -144.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,022,200
Avg Vol 1,120,544
Day's Range N/A - N/A
Shares Out 111.19M
Stochastic %K 53%
Beta -0.11
Analysts Strong Sell
Price Target $23.40

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of so...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
55 Cambridge Parkway, Suite 6W, Cambridge, United States
SilentBull69
SilentBull69 May. 22 at 3:36 PM
$NCLH $CCL $AMLX It’s a little rainy out here right now, so I’m confined to my tent But they just will not stop screwing with this Stock will they? These banks are corrupt as hell ..and the fact of the matter is, they will never pay a price for all their corruption 😡
0 · Reply
11thestate
11thestate May. 22 at 1:56 PM
$AMLX investors there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/amylyx-pharmaceutical-investor-settlement
0 · Reply
DARKP00L
DARKP00L May. 22 at 12:17 PM
$AMLX 07:59 on May. 22 2026 Amylyx Pharmaceuticals shares are trading higher after the company results from the Phase 2 open-label HELIOS clinical trial of AMX0035. #tradeideas
0 · Reply
SilentBull69
SilentBull69 May. 21 at 7:02 PM
$AMLX The bid is so much higher than the ask, but they still manipulate this. It’s really getting sickening. 
0 · Reply
SilentBull69
SilentBull69 May. 21 at 7:01 PM
$AMLX The bid is so much higher than the ask and they still manipulate this damn Stock I’m really getting sick and tired of these marketmakers and all their corrupt shenanigans 
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 21 at 2:09 PM
$RXRX Good Morning 💎☕️ Bio Game Changers!! $SMMT $SANA $AMLX
0 · Reply
fantastex
fantastex May. 20 at 7:10 PM
$CRSR similar Pattern seen in $LYEL and $AMLX Pt $25
1 · Reply
LoveRetailFroth
LoveRetailFroth May. 20 at 1:12 PM
$AMLX Good Morning my Bio 💎s☕️ $SANA $SMMT $RXRX
0 · Reply
laaarsas
laaarsas May. 20 at 12:53 PM
$AMLX What people think of LUCIDITY?
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 19 at 6:10 PM
$AMLX Load Up $40 stock 🚀💎
0 · Reply
Latest News on AMLX
Amylyx sees cash runway into 2028

2026-05-07T16:21:43.000Z - 15 days ago

Amylyx sees cash runway into 2028


Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 15 days ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026


Amylyx Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 15 days ago

Amylyx Pharmaceuticals Earnings release: Q1 2026


Amylyx Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 15 days ago

Amylyx Pharmaceuticals Quarterly report: Q1 2026


Amylyx announces launch of U.S. EAP for adults with PBH

2026-05-05T11:36:12.000Z - 17 days ago

Amylyx announces launch of U.S. EAP for adults with PBH


Amylyx price target raised to $21 from $19 at Mizuho

2026-04-28T10:58:40.000Z - 24 days ago

Amylyx price target raised to $21 from $19 at Mizuho


Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 weeks ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing


Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 weeks ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing


Amylyx price target raised to $30 from $25 at Guggenheim

2026-03-19T10:50:43.000Z - 2 months ago

Amylyx price target raised to $30 from $25 at Guggenheim


Amylyx price target raised to $34 from $28 at H.C. Wainwright

2026-03-04T14:38:10.000Z - 2 months ago

Amylyx price target raised to $34 from $28 at H.C. Wainwright


Amylyx files automatic mixed securities shelf

2026-03-03T13:12:32.000Z - 2 months ago

Amylyx files automatic mixed securities shelf


Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025


Amylyx Pharmaceuticals Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Annual report: Q4 2025


Amylyx Pharmaceuticals Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Earnings release: Q4 2025


Amylyx reports Q4 EPS (30c), consensus (34c)

2026-03-03T12:37:16.000Z - 2 months ago

Amylyx reports Q4 EPS (30c), consensus (34c)


Amylyx initiated with a Buy at Stifel

2026-03-02T21:11:21.000Z - 2 months ago

Amylyx initiated with a Buy at Stifel


Amylyx Pharmaceuticals Slides: Corporate presentation

Mar 2, 2026, 6:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Slides: Corporate presentation


Amylyx price target raised to $19 from $15 at BofA

2026-02-20T12:26:13.000Z - 3 months ago

Amylyx price target raised to $19 from $15 at BofA


Amylyx price target raised to $19 from $18 at Mizuho

2026-02-19T12:36:40.000Z - 3 months ago

Amylyx price target raised to $19 from $18 at Mizuho


Amylyx price target raised to $19 from $18 at Mizuho

2026-02-19T12:29:43.000Z - 3 months ago

Amylyx price target raised to $19 from $18 at Mizuho


Amylyx price target raised to $28 from $20 at H.C. Wainwright

2026-02-10T11:19:36.000Z - 3 months ago

Amylyx price target raised to $28 from $20 at H.C. Wainwright


Amylyx selects AMX0318 as development candidate for PBH

2026-01-08T12:16:47.000Z - 4 months ago

Amylyx selects AMX0318 as development candidate for PBH


Amylyx price target lowered to $15 from $16 at BofA

2025-12-19T14:11:21.000Z - 5 months ago

Amylyx price target lowered to $15 from $16 at BofA


Amylyx price target raised to $18 from $16 at Mizuho

2025-11-10T12:31:55.000Z - 6 months ago

Amylyx price target raised to $18 from $16 at Mizuho


Amylyx price target raised to $20 from $16 at H.C. Wainwright

2025-11-07T13:05:38.000Z - 7 months ago

Amylyx price target raised to $20 from $16 at H.C. Wainwright


Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025


Amylyx Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Amylyx Pharmaceuticals Quarterly report: Q3 2025


Amylyx Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Amylyx Pharmaceuticals Earnings release: Q3 2025


Amylyx Pharmaceuticals Slides: Corporate Presentation

Sep 12, 2025, 7:30 AM EDT - 9 months ago

Amylyx Pharmaceuticals Slides: Corporate Presentation


Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025


Amylyx Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Amylyx Pharmaceuticals Quarterly report: Q2 2025


Amylyx Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Amylyx Pharmaceuticals Earnings release: Q2 2025


Amylyx Pharmaceuticals Transcript: Status Update

Jul 13, 2025, 9:00 PM EDT - 11 months ago

Amylyx Pharmaceuticals Transcript: Status Update


Amylyx Pharmaceuticals Press release: Status Update

Jul 13, 2025, 9:00 PM EDT - 11 months ago

Amylyx Pharmaceuticals Press release: Status Update


Amylyx Pharmaceuticals Slides: Status Update

Jul 13, 2025, 9:00 PM EDT - 11 months ago

Amylyx Pharmaceuticals Slides: Status Update


Amylyx Pharmaceuticals Slides: Investor Presentation

Jun 2, 2025, 4:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Slides: Investor Presentation


Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2025


Amylyx Pharmaceuticals Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Quarterly report: Q1 2025


Amylyx Pharmaceuticals Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings release: Q1 2025


SilentBull69
SilentBull69 May. 22 at 3:36 PM
$NCLH $CCL $AMLX It’s a little rainy out here right now, so I’m confined to my tent But they just will not stop screwing with this Stock will they? These banks are corrupt as hell ..and the fact of the matter is, they will never pay a price for all their corruption 😡
0 · Reply
11thestate
11thestate May. 22 at 1:56 PM
$AMLX investors there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/amylyx-pharmaceutical-investor-settlement
0 · Reply
DARKP00L
DARKP00L May. 22 at 12:17 PM
$AMLX 07:59 on May. 22 2026 Amylyx Pharmaceuticals shares are trading higher after the company results from the Phase 2 open-label HELIOS clinical trial of AMX0035. #tradeideas
0 · Reply
SilentBull69
SilentBull69 May. 21 at 7:02 PM
$AMLX The bid is so much higher than the ask, but they still manipulate this. It’s really getting sickening. 
0 · Reply
SilentBull69
SilentBull69 May. 21 at 7:01 PM
$AMLX The bid is so much higher than the ask and they still manipulate this damn Stock I’m really getting sick and tired of these marketmakers and all their corrupt shenanigans 
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 21 at 2:09 PM
$RXRX Good Morning 💎☕️ Bio Game Changers!! $SMMT $SANA $AMLX
0 · Reply
fantastex
fantastex May. 20 at 7:10 PM
$CRSR similar Pattern seen in $LYEL and $AMLX Pt $25
1 · Reply
LoveRetailFroth
LoveRetailFroth May. 20 at 1:12 PM
$AMLX Good Morning my Bio 💎s☕️ $SANA $SMMT $RXRX
0 · Reply
laaarsas
laaarsas May. 20 at 12:53 PM
$AMLX What people think of LUCIDITY?
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 19 at 6:10 PM
$AMLX Load Up $40 stock 🚀💎
0 · Reply
SilentBull69
SilentBull69 May. 19 at 2:18 PM
$NCLH $CCL $AMLX Still out here camping and glad to be away from all this corruption But checked in this morning In case you all, haven’t figured it out yet. Wall Street uses specialized AI and high-frequency algorithms to scan news feeds in microseconds. They dump millions of shares before a human eye can even finish reading a headline The these computers are programmed to intentionally drive the stock price down to trigger retail stop-losses Once retail traders (us) sell at a loss, the computer instantly buys those cheap shares up Then our AI market places massive buy or sell orders and then cancel them a millisecond later. This creates a fake illusion of market demand or panic, tricking “human traders” into making bad moves. The executives who put out fake guidance to pump a stock before crashing it—combined with the predatory computers running the order books—have turned the market into a completely rigged environment for humans AI has destroyed our stock market….period
4 · Reply
LoveRetailFroth
LoveRetailFroth May. 19 at 1:41 PM
$AMLX Good Morning ☕️ Great Wolfram data. $70 in 18 months ☕️
0 · Reply
laaarsas
laaarsas May. 19 at 12:06 PM
$AMLX So what's the catch here? Give me all the negatives.
1 · Reply
ajmore
ajmore May. 18 at 6:52 PM
$AMLX keep your eyes on the ball! our avexitide play within win. coming down with the etfs is just noise.
2 · Reply
ajmore
ajmore May. 16 at 6:52 AM
$AMLX eyes on the options chains! avexitide data, amlx0114 data and we could be kissing the 35 dollars a share. Wolfram data means 8 usd a share. Avexitide dcf is 5bln. AMX0114 should mean another 5bln. neither is priced in! If you search well you will know why the EAP program was launched! the BPH community know its working. 🚀
2 · Reply
SilentBull69
SilentBull69 May. 15 at 6:21 PM
$AMLX Enough of this fucing sabotage bullsh*t..!!! I see enough of this in the cruise lines. Now I gotta see it in this too. 😡 There needs to be a law that any institution that owns shares in a particular company cannot, and I mean  CANNOT lend those same shares out to the motherfucing SHORTS  this corrupt sh*t…HAS TO STOP….!!!!
0 · Reply
LoveRetailFroth
LoveRetailFroth May. 15 at 5:09 PM
$AMLX AMX0035 Phase 2 data release. WOLFRAM SYNDROME ! 🚀
0 · Reply
11thestate
11thestate May. 15 at 2:30 PM
Don't forget that there is also an important settlement to watch for $AMLX We have every detail, including how investors can get paid: https://11th.com/cases/amylyx-pharmaceutical-investor-settlement
1 · Reply
ajmore
ajmore May. 15 at 12:53 PM
$AMLX Invus Group reports 1.1% position in Amylyx Pharma!.
1 · Reply
SilentBull69
SilentBull69 May. 14 at 9:21 PM
$AMLX If somebody wants to load up … and not already on board now is the time ✌️
0 · Reply
Daedal
Daedal May. 14 at 7:33 PM
$AMLX Slowly buying Leaps.
0 · Reply
Daedal
Daedal May. 14 at 7:29 PM
$AMLX Gift. Goldman expects approval.
0 · Reply